|
NRIP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.130600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.868000E-01 |
| Normal-vs-Stage2 |
8.435600E-02 |
| Normal-vs-Stage3 |
8.999800E-01 |
| Normal-vs-Stage4 |
1.039050E-01 |
| Stage1-vs-Stage2 |
9.162300E-03 |
| Stage1-vs-Stage3 |
2.919400E-01 |
| Stage1-vs-Stage4 |
5.101500E-03 |
| Stage2-vs-Stage3 |
1.523390E-01 |
| Stage2-vs-Stage4 |
6.762800E-01 |
| Stage3-vs-Stage4 |
1.739160E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.790400E-01 |
| Normal-vs-AfricanAmerican |
1.090180E-01 |
| Normal-vs-Asian |
9.830200E-01 |
| Caucasian-vs-AfricanAmerican |
1.910370E-02 |
| Caucasian-vs-Asian |
6.393600E-01 |
| AfricanAmerican-vs-Asian |
1.849770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.919600E-01 |
| Normal-vs-Female |
9.366600E-01 |
| Male-vs-Female |
9.272400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.171390E-01 |
| Normal-vs-Age(41-60Yrs) |
9.954000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.239200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.122000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.771800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.43719999999392E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.217800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.057200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.250400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.691800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.626200E-02 |
| Classical-VS-Follicular |
3.376600E-04 |
| Classical-VS-Other |
9.791000E-01 |
| Classical-VS-Normal |
2.280800E-01 |
| Tall-VS-Follicular |
8.349700E-02 |
| Tall-VS-Other |
7.153600E-01 |
| Tall-VS-Normal |
5.957600E-01 |
| Follicular-VS-Other |
4.336400E-01 |
| Follicular-VS-Normal |
1.542430E-02 |
| Other-VS-Normal |
8.100200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.917400E-01 |
| Normal-vs-N1 |
9.849400E-01 |
| N0-vs-N1 |
9.922000E-01 |
|
|
